EASTHAM KARIN 4
4 · VERACYTE, INC. · Filed Dec 8, 2025
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
EASTHAM KARIN
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-05$7.94/sh+10,000$79,400→ 23,554 total - Sale
Common Stock
2025-12-05$44.52/sh−6,392$284,571→ 27,162 total - Sale
Common Stock
2025-12-05$45.84/sh−12,808$587,080→ 14,354 total - Sale
Common Stock
2025-12-05$46.59/sh−800$37,272→ 13,554 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-05−10,000→ 0 totalExercise: $7.94Exp: 2027-06-07→ Common Stock (10,000 underlying)
Footnotes (5)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $44.22 to $44.91. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F3]Represents weighted average sales price. Sale prices for the transactions range from $45.28 to $46.27. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F4]Represents weighted average sales price. Sale prices for the transactions range from $46.32 to $46.98. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F5]The option is fully vested.